Gadopentetate dimeglumine (CAS 86050-77-3)
CAS Number:
86050-77-3
Molecular Weight:
938
Molecular Formula:
C28H54GdN5O20
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Gadopentetate dimeglumine is a contrast agent for magnetic resonance imaging (MRI) to enhance the visibility of internal structures. It functions by binding to the paramagnetic ion gadolinium, which shortens the relaxation times of water protons in tissues, leading to an increase in signal intensity. This allows for improved visualization of blood vessels, tumors, and other abnormalities during MRI scans. Gadopentetate dimeglumine works by altering the magnetic properties of tissues, leading to enhanced contrast in the resulting images. It achieves this by interacting with the surrounding water molecules and altering the relaxation rates of nearby protons, ultimately leading to improved image quality and diagnostic accuracy in MRI.
Gadopentetate dimeglumine (CAS 86050-77-3) References
- A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal. | Towbin, AJ., et al. 2021. Pediatr Radiol. 51: 457-470. PMID: 33399985
- Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients. | Towbin, AJ., et al. 2021. Pediatr Radiol. 51: 2568-2580. PMID: 34286351
- New Pharmacokinetic Parameters of Imaging Substrates Quantified from Rat Liver Compartments. | Pastor, CM. and Brouwer, KLR. 2022. Drug Metab Dispos. 50: 58-64. PMID: 34670777
- Dynamic contrast-enhanced magnetic resonance perfusion volumetrics can differentiate tuberculosis of the spine and vertebral malignancy. | Verma, M., et al. 2022. Acta Radiol. 63: 1504-1512. PMID: 34806421
- Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity. | Chen, D., et al. 2022. J Int Med Res. 50: 3000605221076977. PMID: 35118901
- Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium-Based Contrast Agents. | Yao, X., et al. 2022. J Magn Reson Imaging. 56: 835-845. PMID: 35166409
- A low albumin level as a risk factor for transient severe motion artifact induced by gadoxetate disodium administration: A retrospective observational study with free-breathing dynamic MRI and an experimental study in rats. | Sugiura, T., et al. 2022. PLoS One. 17: e0265588. PMID: 35303023
- Gadolinium Enhances Dual-energy Computed Tomography Scan of Pulmonary Artery. | Xie, A., et al. 2022. Curr Med Sci. 42: 1310-1318. PMID: 36190598
- Novel Salinomycin-Based Paramagnetic Complexes-First Evaluation of Their Potential Theranostic Properties. | Pashkunova-Martic, I., et al. 2022. Pharmaceutics. 14: PMID: 36365139
- Effect of gadopentetate dimeglumine on bone growth in zebrafish caudal fins. | Tang, R., et al. 2023. Toxicol Lett. 374: 11-18. PMID: 36496117
- Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer. | Liu, L., et al. 2023. Diagnostics (Basel). 13: PMID: 36832236
- Preparation and In Vitro Evaluation of a Gadolinium-Containing Vitamin E TPGS Micelle as a Potential Contrast Agent for MR Imaging. | Gai, Y., et al. 2023. Pharmaceutics. 15: PMID: 36839723
- Gadolinium-based MR cisternography with prepontine cisternal routine for evaluating distribution pattern of intrathecal targeted drug delivery in pain management. | Zhou, H., et al. 2023. Drug Deliv. 30: 2189588. PMID: 36927215
- Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T2 -Weighted MR Tumor Imaging. | Wei, M., et al. 2023. Small. e2300015. PMID: 37029574
- Dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian tumor categorization: comparison with apparent diffusion coefficient histogram analysis and the tumor cell proliferation marker. | Zhou, Q., et al. 2023. Am J Transl Res. 15: 1862-1870. PMID: 37056838
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gadopentetate dimeglumine, 25 mg | sc-495496 | 25 mg | $158.00 |